Jove
Visualize
Contact Us

Related Experiment Videos

[Drug vigilance].

Jean-Louis Imbs1, Marie Welsch

  • 1Service d'hypertension artérielle, maladies vasculaires et pharmacologie clinique Centre régional de pharmacovigilance d'Alsace Hôpitaux universitaires de Strasbourg Hôpital civil B.P. 426, 67091 Strasbourg.

La Revue Du Praticien
|April 16, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Digital necrosis related to gemcitabine].

Presse medicale (Paris, France : 1983)·2010
Same author

[Inefficacy of vitamin K antagonists in an human immunodeficiency virus seropositive patient taking nevirapine].

Presse medicale (Paris, France : 1983)·2009
Same author

[Personified prescribing. Drug compliance].

La Revue du praticien·2009
Same author

Acute thrombosis of an aortobifemoral graft after cancer surgery and withdrawal of clopidogrel.

Therapie·2007
Same author

[Pharmacokinetics of cardiovascular drugs in the elderly].

Bulletin de l'Academie nationale de medecine·2007
Same author

Can colchicine potentiate the anticoagulant effect of fluindione?

European journal of clinical pharmacology·2005
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Drug vigilance identifies and analyzes adverse drug reactions to ensure patient safety. This process involves specialists, databases, and literature to confirm drug side effects and update prescriptions.

Area of Science:

  • Pharmacovigilance and drug safety.
  • Public health surveillance.
  • Clinical pharmacology.

Context:

  • Drug vigilance systems are essential for monitoring medication safety post-market.
  • Adverse drug reactions (ADRs) pose a significant risk to public health.
  • Current systems rely on healthcare professional reporting and data analysis.

Purpose:

  • To identify, analyze, and anticipate adverse drug reactions.
  • To ensure the safe use of medications and update prescribing information.
  • To establish causality between drug exposure and potential side effects.

Summary:

  • Drug vigilance involves specialists flagging potential side effects, which are then investigated.
  • Causality is assessed using professional judgment, vigilance networks, databases, and literature.

Related Experiment Videos

  • Epidemiological analysis is employed for low-risk drug-associated events.
  • Impact:

    • Crucial for maintaining public health and medication safety.
    • Facilitates timely updates to drug prescriptions and safety guidelines.
    • Integrates data from pharmaceutical companies and public reporting networks.